Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B

The aim of the present study was to investigate the predictive value of baseline serum microRNA (miRNA)-125b for nucleos(t)ide analogues (NAs) in patients with chronic hepatitis B (CHB). A total of 66 patients with Be antigen (HBeAg)-positive CHB received NAs therapy for 144 weeks. Serum miRNA-125b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Pu, Dong, Minhui, Wang, Jinyu, Li, Fahong, Zhang, Jiming, Gu, Jingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176193/
https://www.ncbi.nlm.nih.gov/pubmed/30344656
http://dx.doi.org/10.3892/etm.2018.6685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176193/
https://www.ncbi.nlm.nih.gov/pubmed/30344656
http://dx.doi.org/10.3892/etm.2018.6685

Ejemplares similares